RI biotech Bolden Therapeutics raises $1.5M to advance Alzheimer's work
Bolden, a Brown University spinoff, is working on neurogenesis — the formation of new brain cells in adults. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 22, 2024 Category: Biotechnology Authors: Mary Serreze Source Type: news

New blood test that screens for Alzheimer ’s may be a step closer to reality
A test could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show. (Source: PsycPORT.com)
Source: PsycPORT.com - January 22, 2024 Category: Psychiatry Source Type: news

Alzheimer's Blood Test Shows High Diagnostic Accuracy
(MedPage Today) -- A commercially available plasma assay that measured phosphorylated tau at threonine 217 (p-tau217) accurately identified biological Alzheimer's disease, data from three cohorts showed. Across all cohorts, the p-tau217 assay... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - January 22, 2024 Category: Neurology Source Type: news

The early Alzheimer's symptom you could spot while parking your car
Identifying Alzheimer's early is key, but differentiating between symptoms and other health conditions can be difficult (Source: Daily Express - Health)
Source: Daily Express - Health - January 22, 2024 Category: Consumer Health News Source Type: news

Combating Alzheimer ’s With Focused Ultrasound Drug Delivery
An emerging combination of focused ultrasound therapy with a recently approved medication could be our best treatment for Alzheimer ’s disease to date. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Study IDs Proportion of Dementia Cases Attributable to Known Risk Factors
FRIDAY, Jan. 19, 2024 -- Known risk factors account for a considerable proportion of Alzheimer disease and related dementia (ADRD) cases, with unequal distribution across race and ethnic groups, according to a study published online Jan. 17 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2024 Category: Pharmaceuticals Source Type: news

Unlocking the potential of imaging in Alzheimer ’s disease care
Jan Makela.In the U.S., more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. Alzheimer’s has been a formidable challenge for our society, patients, caregivers, and healthcare systems for decades. The disease affects memory, thinking, and behavior. Its symptoms typically start with mild cognitive impairment and eventually grow severe enough to interfere with daily tasks. Historically, medications and therapies have...
Source: AuntMinnie.com Headlines - January 19, 2024 Category: Radiology Authors: Jan Makela Tags: Practice Management Molecular Imaging MRI Neuroradiology Source Type: news

Transcranial Stimulation May Improve Cognitive Function Of Alzheimer ’s Patients
New electronic brain stimulation therapies may be the first step to finding a long-awaited cure for Alzheimer ’s Disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 17, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Can looking after teeth and gums protect against dementia?
People with early-stage Alzheimer ’ s disease or mild cognitive impairment are already taking part in research to investigate whether improving oral health can slow memory loss but even more people are needed to help. The MySmile study, led by the University of Bristol, wants to find out if a daily brushing routine could help to protect against dementia. (Source: University of Bristol news)
Source: University of Bristol news - January 16, 2024 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Dental School, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Translational Health Sciences; Press Release Source Type: news

Dementia warning: Toothbrush habit is linked to increased risk of disease, says new study
Dementia is characterized by an impaired ability to remember, think, and make decisions, with the most common form being Alzheimer's disease. (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2024 Category: Consumer Health News Source Type: news

A New Treatment For Alzheimer ’s Improves How Drugs Reach The Brain
A new study explored the combination of focused ultrasound and aducanumab, an anti-amyloid antibody, to treat Alzheimer's by improving delivery of the drug to the brain. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 14, 2024 Category: Pharmaceuticals Authors: Gabriel A. Silva, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare standard Source Type: news

Neurotech Takes The Stage At JPM 2024
Neurotechnology, cognitive biomarkers, Alzheimer's drugs, diagnostics, AI, VR, and more were topics of investor discussion at the 2024 JP Morgan Healthcare Conference. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 13, 2024 Category: Pharmaceuticals Authors: Naveen Rao, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

UMass Amherst wins grant to compare predictive Alzheimer's models
A University of Massachusetts Amherst biomedical imaging and data science team has secured a grant from the National Institutes of Health (NIH) to develop a deep-learning model for predicting Alzheimer’s disease at least two years before symptom onset. Principal investigators are Madalina Fiterau, PhD, of the university's Manning College of Information and Computer Sciences, and Joyita Dutta, PhD, of its Biomedical Imaging and Data Science Lab (BIDSLab). The team will use brain MRIs taken in real-world settings and multimodal clinical data to create predictive models for Alzheimer's. As part of the announcement, they n...
Source: AuntMinnie.com Headlines - January 12, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aM... Diagnostics, Neurology, FDA Darmiyan, BrainSee, Alzheimer's (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2024 Category: Pharmaceuticals Source Type: news

Myrobalan raises $24M round to bring central nervous system drug into clinic
A biotech developing an oral drug to repair damage and restore neural function in patients with such conditions as Alzheimer ’s disease, ALS and multiple sclerosis has raised a round of venture capital. Myrobalan Therapeutics of Medford, Mass. announced a $24 million Series A investment round on Wednesday morning. The round was led by Co-win Healthcare Fund of China, alongside new and existing investors, including 3E B ioventures Capital, AB Magnitude Ventures Group and Guan Zi Equity Investment… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 11, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news